Contrast-enhanced 3D MRA is emerging as a powerful noninvasive imaging modality for the assessment of patients with PVD. Its clinical utility using current technology has already been well established, and the continuous development of hard- and software will likely result in significantly improved performance. Thus, Gd-enhanced MRA is likely to emerge as the dominant noninvasive imaging modality for PVD worldwide.